{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:20:38Z","timestamp":1771010438517,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10067-023-06805-3","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T06:14:22Z","timestamp":1700201662000},"page":"435-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ultrasound reveals a high prevalence of CPPD in consecutive patients with knee pain"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6881-8197","authenticated-orcid":false,"given":"Edoardo","family":"Cipolletta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Francioso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3972-4458","authenticated-orcid":false,"given":"Gianluca","family":"Smerilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Di Battista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7251-7784","authenticated-orcid":false,"given":"Emilio","family":"Filippucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,17]]},"reference":[{"key":"6805_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/ard.2010.139105","volume":"70","author":"W Zhang","year":"2011","unstructured":"Zhang W, Doherty M, Bardin T, Barskova V, Guerne P-A, Jansen TL et al (2011) European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis 70:563\u2013570. https:\/\/doi.org\/10.1136\/ard.2010.139105","journal-title":"Ann Rheum Dis"},{"key":"6805_CR2","first-page":"981","volume":"27","author":"R Ramonda","year":"2009","unstructured":"Ramonda R, Musacchio E, Perissinotto E, Sartori L, Punzi L, Corti MC et al (2009) Prevalence of chondro-calcinosis in Italian subjects from northeastern Italy. The Pro.V.A. (PROgetto Veneto Anziani) Study. Clin Exp Rheumatol 27:981\u2013984","journal-title":"Clin Exp Rheumatol"},{"key":"6805_CR3","first-page":"819","volume":"23","author":"F Salaffi","year":"2005","unstructured":"Salaffi F, De Angelis R, Grassi W, Avaltroni D, Blasetti P, Brecciaroli D et al (2005) Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I The MAPPING study. Clin Exp Rheumatol 23:819\u2013828","journal-title":"Clin Exp Rheumatol"},{"key":"6805_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/ard.62.6.513","volume":"62","author":"RL Neame","year":"2003","unstructured":"Neame RL, Carr AJ, Muir K, Doherty M (2003) UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis 62:513\u2013518. https:\/\/doi.org\/10.1136\/ard.62.6.513","journal-title":"Ann Rheum Dis"},{"key":"6805_CR5","first-page":"1241","volume":"16","author":"D Felson","year":"1989","unstructured":"Felson D, Anderson J, Naimark A, Kannel W, Meenan R (1989) The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study. J Rheumatol 16:1241\u20131245","journal-title":"J Rheumatol"},{"key":"6805_CR6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1136\/ANNRHEUMDIS-2017-212542","volume":"77","author":"G Filippou","year":"2018","unstructured":"Filippou G, Scir\u00e8 CA, Adinolfi A, Damjanov NS, Carrara G, Bruyn GAW et al (2018) Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints\u2014an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Sub-task force study. Ann Rheum Dis 77:1194\u20131199. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2017-212542","journal-title":"Ann Rheum Dis"},{"key":"6805_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/ANNRHEUMDIS-2020-217998","volume":"80","author":"G Filippou","year":"2021","unstructured":"Filippou G, Scanu A, Adinolfi A, Toscano C, Gambera D, Largo R et al (2021) Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study. Ann Rheum Dis 80:261\u2013267. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2020-217998","journal-title":"Ann Rheum Dis"},{"key":"6805_CR8","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3899\/jrheum.161057","volume":"44","author":"G Filippou","year":"2017","unstructured":"Filippou G, Scir\u00e8 CA, Damjanov N, Adinolfi A, Carrara G, Picerno V et al (2017) Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: a study by the OMERACT calcium pyrophosphate deposition disease ultrasound subtask force. J Rheumatol 44:1744\u20131749. https:\/\/doi.org\/10.3899\/jrheum.161057","journal-title":"J Rheumatol"},{"key":"6805_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/J.JOCA.2021.01.007","volume":"29","author":"E Cipolletta","year":"2021","unstructured":"Cipolletta E, Filippou G, Scir\u00e8 CA, Di MA, Di BJ, Salaffi F et al (2021) The diagnostic value of conventional radiography and musculoskeletal ultrasonography in calcium pyrophosphate deposition disease: a systematic literature review and meta-analysis. Osteoarthr Cartil 29:619\u2013632. https:\/\/doi.org\/10.1016\/J.JOCA.2021.01.007","journal-title":"Osteoarthr Cartil"},{"key":"6805_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/ART.42619","author":"A Abhishek","year":"2023","unstructured":"Abhishek A, Tedeschi SK, Pascart T, Latourte A, Dalbeth N, Neogi T et al (2023) The 2023 ACR\/EULAR classification criteria for calcium pyrophosphate deposition disease. Arthritis Rheumatol. https:\/\/doi.org\/10.1002\/ART.42619","journal-title":"Arthritis Rheumatol"},{"key":"6805_CR11","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2665-9913(23)00136-4","volume":"5","author":"S Sirotti","year":"2023","unstructured":"Sirotti S, Terslev L, Filippucci E, Iagnocco A, Moller I, Naredo E et al (2023) Development and validation of an OMERACT ultrasound scoring system for the extent of calcium pyrophosphate crystal deposition at the joint level and patient level. Lancet Rheumatol 5:e474\u2013e482. https:\/\/doi.org\/10.1016\/S2665-9913(23)00136-4","journal-title":"Lancet Rheumatol"},{"key":"6805_CR12","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1136\/annrheumdis-2017-211585","volume":"76","author":"I M\u00f6ller","year":"2017","unstructured":"M\u00f6ller I, Janta I, Backhaus M, Ohrndorf S, Bong DA, Martinoli C et al (2017) The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology. Ann Rheum Dis 76:1974\u20131979. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211585","journal-title":"Ann Rheum Dis"},{"key":"6805_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4081\/reumatismo.2014.807","volume":"66","author":"G Filippou","year":"2015","unstructured":"Filippou G, Picerno V, Adinolfi A, Di Sabatino V, Bertoldi I, Galeazzi M et al (2015) Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: the axial scan of the meniscus. Reumatismo 66:318\u2013321. https:\/\/doi.org\/10.4081\/reumatismo.2014.807","journal-title":"Reumatismo"},{"key":"6805_CR14","doi-asserted-by":"publisher","first-page":"vii18","DOI":"10.1093\/rheumatology\/kes332","volume":"51","author":"E Filippucci","year":"2012","unstructured":"Filippucci E, Di Geso L, Grassi W (2012) Tips and tricks to recognize microcrystalline arthritis. Rheumatology 51:vii18-21. https:\/\/doi.org\/10.1093\/rheumatology\/kes332","journal-title":"Rheumatology"},{"key":"6805_CR15","doi-asserted-by":"publisher","unstructured":"Cipolletta E, Abhishek A, Di Matteo A, Grassi W, Filippucci E (2023) Dynamic assessment of the double contour sign by ultrasonography helps to distinguish between gout and calcium pyrophosphate deposition disease. RMD Open 9. https:\/\/doi.org\/10.1136\/RMDOPEN-2022-002940","DOI":"10.1136\/RMDOPEN-2022-002940"},{"key":"6805_CR16","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1136\/ANNRHEUMDIS-2022-222316","volume":"81","author":"G Filippou","year":"2022","unstructured":"Filippou G, Pacini G, Sirotti S, Zadory M, Carboni D, Damiani A et al (2022) Comparison of ultrasound attenuation by calcium pyrophosphate, hydroxyapatite and monosodium urate crystals: a proof-of-concept study. Ann Rheum Dis 81:1199\u20131201. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2022-222316","journal-title":"Ann Rheum Dis"},{"key":"6805_CR17","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3899\/jrheum.181095","volume":"46","author":"GA Bruyn","year":"2019","unstructured":"Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB et al (2019) OmeRACT definitions for ultrasonographic pathologies and elementary lesions of rheumatic disorders 15 years on. J Rheumatol 46:1388\u20131393. https:\/\/doi.org\/10.3899\/jrheum.181095","journal-title":"J Rheumatol"},{"key":"6805_CR18","doi-asserted-by":"publisher","unstructured":"Sanmarti R, Panella D, Brancos M, Canela J, Collado A, Brugues J (1993) Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia. Ann Rheum Dis 52:418\u2013422. https:\/\/doi.org\/10.1136\/ard.52.6.418","DOI":"10.1136\/ard.52.6.418"},{"key":"6805_CR19","doi-asserted-by":"publisher","unstructured":"Riecke BF, Christensen R, Torp-Pedersen S, Boesen M, Gudbergsen H, Bliddal H (2014) An ultrasound score for knee osteoarthritis: a cross-sectional validation study. Osteoarthr Cartil 22:1675\u20131691. https:\/\/doi.org\/10.1016\/J.JOCA.2014.06.020","DOI":"10.1016\/J.JOCA.2014.06.020"},{"key":"6805_CR20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1136\/ANNRHEUMDIS-2014-206774","volume":"75","author":"GAW Bruyn","year":"2016","unstructured":"Bruyn GAW, Naredo E, Damjanov N, Bachta A, Baudoin P, Hammer HB et al (2016) An OMERACT reliability exercise of inflammatory and structural abnormalities in patients with knee osteoarthritis using ultrasound assessment. Ann Rheum Dis 75:842\u2013846. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2014-206774","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6805_CR21","first-page":"254","volume":"34","author":"G Filippou","year":"2016","unstructured":"Filippou G, Adinolfi A, Cimmino MA, Scir\u00e8 CA, Carta S, Lorenzini S et al (2016) Diagnostic accuracy of ultrasound, conventional radiography and synovial fluid analysis in the diagnosis of calcium pyrophosphate dihydrate crystal deposition disease. Clin Exp Rheumatol 34(2):254\u201360","journal-title":"Clin Exp Rheumatol"},{"key":"6805_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4081\/REUMATISMO.2021.1403","volume":"73","author":"S Sirotti","year":"2021","unstructured":"Sirotti S, Gutierrez M, Pineda C, Clavijo-Cornejo D, Serban T, Dumitru A et al (2021) Accuracy of synovial fluid analysis compared to histology for the identification of calcium pyrophosphate crystals: an ancillary study of the OMERACT US Working Group - CPPD subgroup. Reumatismo 73:106\u2013110. https:\/\/doi.org\/10.4081\/REUMATISMO.2021.1403","journal-title":"Reumatismo"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06805-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T15:08:56Z","timestamp":1704726536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06805-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6805"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06805-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,17]]},"assertion":[{"value":"2 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"E.F. has received speaking fees from AbbVie, Bristol-Myers Squibb, Celgene, Novartis, Pfizer, Roche, and Union Chimique Belge Pharma outside the submitted work.All other authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}